Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End‐Stage Kidney Disease
Background Heart failure with reduced ejection fraction (HFrEF) is a chronic disease with substantial mortality. Management of HFrEF has seen significant breakthrough after the launch of neprilysin inhibitor. The PARADIGM‐HF (Prospective Comparison of ARNI with ACEI to Determine Impacton Global Mort...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Wiley
2022-09-01
|
| Colección: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Materias: | |
| Acceso en línea: | https://www.ahajournals.org/doi/10.1161/JAHA.122.026407 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|